• Drosophila Keap1 Forms Nuclear Condensates Under Oxidative S

  2026-07-03

  This study uncovers how Drosophila Keap1 protein assembles stable nuclear condensates in response to oxidative stress, requiring both its N- and C-terminal domains and intrinsically disordered regions. These findings clarify a novel nuclear mechanism for Keap1 in stress and development, informing future research into Keap1-Nrf2 pathway regulation.

• Novobiocin: Applied Workflows in Antiparasitic and Resistanc

  2026-07-02

  Novobiocin, a potent aminocoumarin antibiotic, is transforming antibacterial resistance and antiparasitic assay design with its dual targeting of DNA gyrase and Hsp90. This article unpacks advanced workflows, real-world troubleshooting, and experimental insights—empowering your research with both evidence-backed protocols and the reliability of APExBIO’s high-purity standard.

• Calpeptin: Advanced Calpain Inhibitor Workflows in Fibrosis

  2026-07-02

  Calpeptin enables precise, nanomolar-level calpain inhibition for investigations into pulmonary fibrosis and extracellular vesicle modulation. This guide translates recent breakthrough findings and expert protocols into actionable workflows, troubleshooting strategies, and comparative insights for high-impact cell biology research.

• Angiotensin II (A1042): Technical Protocols and QC in Vascul

  2026-07-01

  Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) is a potent vasopressor and GPCR agonist, widely used to model mechanisms of hypertension, cardiovascular remodeling, and vascular smooth muscle cell hypertrophy in preclinical research. This product provides researchers with a reliable reagent for standardized in vitro and in vivo studies, but should not be used in diagnostic or clinical contexts. Proper solubilization, dosing, and storage are essential to maintain activity and experimental consistency.

• Masitinib (AB1010): Technical Use in KIT/PDGFR Inhibition Wo

  2026-07-01

  Masitinib (AB1010) is a phenylaminothiazole-type tyrosine kinase inhibitor designed for research applications requiring selective inhibition of KIT, PDGFRα, and PDGFRβ, particularly in cancer and mastocytosis models. It is best employed in DMSO-based assays demanding high kinase selectivity and is not suitable for protocols requiring water or ethanol solubility or broad-spectrum kinase inhibition.

• Thioredoxin System Shapes CHK1 Inhibitor Response in NSCLC

  2026-06-30

  This study reveals that the thioredoxin system controls sensitivity to CHK1 inhibitors in non-small cell lung cancer by regulating ribonucleotide reductase through redox mechanisms. These findings have practical implications for developing redox-based combination therapies that improve efficacy while limiting toxicity in solid tumor models.

• Quantitative Assessment of UAV vs. Knapsack Pesticide Drift

  2026-06-30

  This study provides a direct field comparison of pesticide spray drift from unmanned aerial vehicles (UAVs) and traditional electric knapsack sprayers (EKS), utilizing Rhodamine B as a quantitative tracer. The findings reveal UAVs produce notably greater drift distances and deposition rates, offering critical data for environmental risk assessment and regulatory guidance.

• Redefining Sensitivity: TCEP Hydrochloride in Translational

  2026-06-29

  Explore how Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) is transforming the landscape of translational research, bridging mechanistic protein chemistry with strategic assay innovation. This article provides actionable insights for researchers seeking to elevate diagnostic sensitivity, workflow reproducibility, and experimental rigor beyond conventional paradigms, while contextualizing APExBIO’s TCEP hydrochloride (SKU: B6055) within the latest ‘capture-and-release’ advancements and protein analysis strategies.

• Demethyleneberberine: Applied Protocols and Troubleshooting

  2026-06-29

  Demethyleneberberine (DMB) is a multi-pathway modulator empowering researchers studying inflammation, neuroprotection, and cancer. This article translates recent breakthroughs and expert workflows into actionable guidance, with protocol tips and troubleshooting for maximizing DMB’s translational impact.

• Hematoxylin and Eosin Staining Kit: Technical Best Practices

  2026-06-28

  The Hematoxylin and Eosin Staining Kit (SKU K1142) provides ready-to-use reagents for reliable visualization of tissue and cellular structures in research settings. It addresses common bottlenecks in histopathological tissue staining, particularly for paraffin-embedded and frozen sections, but is not intended for diagnostic or clinical applications.

• Clodronate Liposomes (K2721): Reliable Macrophage Depletion

  2026-06-27

  This article provides scenario-driven guidance for biomedical researchers leveraging Clodronate Liposomes (SKU K2721) in immune cell modulation, viability, and cytotoxicity assays. By addressing real-world workflow and data interpretation challenges, it demonstrates how this macrophage depletion reagent from APExBIO supports reproducibility, experimental specificity, and protocol optimization in advanced in vivo models.

• Cy5-UTP: Optimized RNA Labeling for FISH and Probe Synthesis

  2026-06-26

  Cy5-UTP (Cyanine 5-UTP) brings high-sensitivity fluorescent RNA labeling to in vitro transcription, FISH, and dual-color array applications, enabling direct probe visualization and multiplex analysis. This guide unpacks advanced workflows, troubleshooting, and practical insights to maximize experimental performance with APExBIO’s Cy5-UTP.

• YANK2 Promotes Glioma Growth via mTOR-Independent p70S6K Pat

  2026-06-26

  This study uncovers YANK2 as a novel oncogenic kinase in glioma, activated by Fyn-mediated phosphorylation, which enhances tumor growth through direct phosphorylation of p70S6K independently of mTOR. The findings point to the Fyn–YANK2–p70S6K axis as a promising therapeutic target and offer new insights into translational control in glioblastoma.

• Necrostatin-1 (Nec-1): Reliable RIP1 Kinase Inhibition in Ce

  2026-06-25

  This article examines real-world laboratory scenarios where Necrostatin-1 (Nec-1), (R)-5-([7-chloro-1H-indol-3-yl]methyl)-3-methylimidazolidine-2,4-dione (SKU A4213) serves as a robust RIP1 kinase inhibitor for necroptosis and cell viability research. Emphasizing data-backed protocols, workflow compatibility, and vendor reliability, we guide biomedical researchers toward reproducible results. Explore how SKU A4213 from APExBIO addresses core challenges in assay consistency and mechanistic studies.

• FXR-KLF11 Axis Suppresses JAK2/STAT3 in CI-AKI Protection

  2026-06-25

  This study reveals that Chenodeoxycholic Acid (CDCA) protects against contrast-induced acute kidney injury (CI-AKI) through FXR-mediated upregulation of KLF11, which suppresses the JAK2/STAT3 inflammatory pathway. The findings highlight the FXR-KLF11 axis as a mechanistic advance and a potential therapeutic target for kidney injury prevention.

457 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page